20:08 EDT Cathie Wood’s ARK Investment bought 201K shares of Crispr Therapeutics today
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on CRSP:
- Dollar Tree upgraded, Microsoft initiated: Wall Street’s top analyst calls
- Crispr Therapeutics downgraded to Neutral from Overweight at Cantor Fitzgerald
- Crispr Therapeutics proposes to elect Sandy Mahatme to board of directos
- CRISPR Therapeutics Proposes New Appointment to the Board of Directors
- Vertex Pharmaceuticals price target raised to $425 from $400 at BofA